These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9255101)

  • 61. Negative mood changes during hormone replacement therapy: a comparison between two progestogens.
    Björn I; Bixo M; Nöjd KS; Nyberg S; Bäckström T
    Am J Obstet Gynecol; 2000 Dec; 183(6):1419-26. PubMed ID: 11120505
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Can hormone replacement therapy be used during medical therapy of endometriosis?
    Edmonds DK; Howell R
    Br J Obstet Gynaecol; 1994 May; 101 Suppl 10():24-6. PubMed ID: 8199100
    [No Abstract]   [Full Text] [Related]  

  • 63. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group.
    Woodruff JD; Pickar JH
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 1):1213-23. PubMed ID: 8178840
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bone mineral density response to estrogen replacement in frail elderly women: a randomized controlled trial.
    Villareal DT; Binder EF; Williams DB; Schechtman KB; Yarasheski KE; Kohrt WM
    JAMA; 2001 Aug; 286(7):815-20. PubMed ID: 11497535
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of progestational agents for postmenopausal hot flushes.
    Roopnarinesingh S
    Int J Gynaecol Obstet; 1982 Apr; 20(2):133-5. PubMed ID: 6125433
    [No Abstract]   [Full Text] [Related]  

  • 66. Effect of medroxyprogesterone acetate plus estradiol on endothelium-dependent vasodilation in postmenopausal women.
    Kawano H; Motoyama T; Hirai N; Yoshimura T; Kugiyama K; Ogawa H; Okamura H; Yasue H
    Am J Cardiol; 2001 Jan; 87(2):238-40, A9. PubMed ID: 11152852
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A randomized, double-blind, placebo-controlled, cross-over trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapy.
    Kirkham C; Hahn PM; Van Vugt DA; Carmichael JA; Reid RL
    Obstet Gynecol; 1991 Jul; 78(1):93-7. PubMed ID: 1828550
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study.
    Harden CL; Herzog AG; Nikolov BG; Koppel BS; Christos PJ; Fowler K; Labar DR; Hauser WA
    Epilepsia; 2006 Sep; 47(9):1447-51. PubMed ID: 16981859
    [TBL] [Abstract][Full Text] [Related]  

  • 70. alpha-Tocopherol and beta-carotene serum levels in post-menopausal women treated with transdermal estradiol and oral medroxyprogesterone acetate.
    Clemente C; Caruso MG; Berloco P; Buonsante A; Giannandrea B; Di Leo A
    Horm Metab Res; 1996 Oct; 28(10):558-61. PubMed ID: 8934216
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Beyond the null hypothesis--do the HERS results disprove the estrogen/coronary heart disease hypothesis?
    Blumenthal RS; Zacur HA; Reis SE; Post WS
    Am J Cardiol; 2000 Apr; 85(8):1015-7. PubMed ID: 10760346
    [No Abstract]   [Full Text] [Related]  

  • 72. [Postmenopausal hormone therapy after WHI and HERS].
    Birkhäuser M; de Geyter C; Keller PJ; Luzuy F
    Gynakol Geburtshilfliche Rundsch; 2004 Oct; 44(4):244-8. PubMed ID: 15459524
    [No Abstract]   [Full Text] [Related]  

  • 73. Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer: a randomized, placebo-controlled trial.
    Simons JP; Schols AM; Hoefnagels JM; Westerterp KR; ten Velde GP; Wouters EF
    Cancer; 1998 Feb; 82(3):553-60. PubMed ID: 9452274
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inappropriate masturbation and schizophrenia.
    Brooks JO; Waikar MV
    J Clin Psychiatry; 2000 Jun; 61(6):451. PubMed ID: 10901350
    [No Abstract]   [Full Text] [Related]  

  • 75. Catamenial mononeuropathy and radiculopathy.
    Cirak B; Guven MB
    J Neurosurg; 1999 Feb; 90(2):374. PubMed ID: 9950514
    [No Abstract]   [Full Text] [Related]  

  • 76. Progesterone treatment in chylothorax associated with pulmonary tuberous sclerosis.
    Jounieaux V; Druelle S; Mayeux I; Grimault E; Charet JC
    Eur Respir J; 1996 Nov; 9(11):2423-5. PubMed ID: 8947095
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of progestational agents in the treatment of undernourished patients with cystic fibrosis.
    Kissner DG
    Pediatr Pulmonol; 2000 Mar; 29(3):244. PubMed ID: 10686049
    [No Abstract]   [Full Text] [Related]  

  • 78. High-dose medroxyprogesterone acetate for the treatment of dysfunctional uterine bleeding in 24 adolescents.
    Aksu F; Madazli R; Budak E; Cepni I; Benian A
    Aust N Z J Obstet Gynaecol; 1997 May; 37(2):228-31. PubMed ID: 9222474
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Medical management of chronic pelvic pain.
    Prentice A
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Jun; 14(3):495-9. PubMed ID: 10962638
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of oestrogen supplementation on postmenopausal urinary stress incontinence: a double-blind placebo-controlled trial.
    Dickson MJ; Salleh S
    BJOG; 2000 Mar; 107(3):433-4. PubMed ID: 10740346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.